Repetto, F. et al. 2022. Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series. Acta Dermato-Venereologica. 102, (Sep. 2022), adv00780. DOI:https://doi.org/10.2340/actadv.v102.2926.